Pomalidomide is a pharmaceutical raw material that is a derivative of thalidomide, modified by the addition of an amino group. It is primarily supplied for use in the manufacturing of antineoplastic agents and has been investigated as an angiogenesis inhibitor and immunomodulator.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 19171-19-8
Thalidomide
pharmaceutical raw material
Altretamine
pharmaceutical raw material
Ixabepilone
pharmaceutical raw material
Betulinic acid
pharmaceutical raw material
Dromostanolone propionate
pharmaceutical raw material
(RS)-lenalidomide
pharmaceutical raw material
6,7-dimethoxy-2-N,2-N-dimethylquinazoline-2,4-diamine
pharmaceutical raw material
Prazosin
pharmaceutical raw material
4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
UVSMNLNDYGZFPF-UHFFFAOYSA-N
C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N